Fitness & muscle
PEG-MGF
Native MGF with a polyethylene glycol tag bolted on to stretch its otherwise minutes-long half-life into something injectable a few times a week; the underlying human data is essentially borrowed from other pegylated IGF-1 work, not PEG-MGF itself.
Research chemical Fitness & muscle
- Full name
- PEGylated Mechano Growth Factor
- Also known as
- Pegylated MGF, PEG MGF
- Regulatory status
- Unapproved research compound, no regulatory approval for any human indication. Sold through the same research-chemical channels as unmodified MGF.
Origin
MGF (mechano growth factor, the IGF-1Ec splice variant) is produced locally in muscle tissue after mechanical loading or damage and is cleared within minutes. PEG-MGF is a synthetic version with polyethylene glycol chains attached to the peptide backbone, a modification used across biologics (PEGylated interferons, PEGylated growth hormone, etc.) specifically to slow renal clearance and proteolysis.
Mechanism
Proposed to act the same way as native MGF, binding IGF-1 receptors on satellite cells to trigger proliferation and fusion into myofibers, but with PEGylation increasing hydrodynamic size and shielding the peptide from clearance so it persists in circulation rather than acting only locally and briefly.
Research summary
Evidence
No PubMed-indexed studies test PEG-MGF itself in animals or humans. What exists is indirect: a first-in-human trial of a differently PEGylated IGF-1 molecule (not MGF) showed PEGylation extended IGF-1 half-life from a matter of hours to roughly 140-200 hours and blunted the hypoglycemia and GH-suppression seen with unmodified IGF-1, demonstrating PEGylation's general effect on this protein family's pharmacokinetics. Separately, human muscle-biopsy studies confirm native MGF mRNA is induced transiently by resistance exercise and that this response is blunted in older adults. A 2026 narrative review of unregulated performance-enhancing peptides lists PEG-MGF among compounds being self-administered off-label and explicitly flags the absence of human pharmacokinetic or efficacy data for it specifically, contrasting it with better-studied compounds in the same drug class.
Evidence tier: Research chemical — see the methodology note for how this is assessed.
Citations
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration — Dominikowski et al. 2026
- First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I — Kletzl et al. 2017
- Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro — Philippou et al. 2009
- Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise — Hameed et al. 2003
Reported benefits
- claimed longer-lasting, more systemic muscle-building effect than native MGF (theoretical, extrapolated from PEGylation's known effect on IGF-1 half-life)
- reduced injection frequency compared to native MGF due to slower clearance
- same satellite-cell activation/hypertrophy claims made for native MGF, unverified for the pegylated form
Dosing protocols reported in the literature & community
These are protocols reported by compounding pharmacies, published trials, or self-experimentation communities — not a prescription. Start low, especially for anything new.
| Route | Reported protocol |
|---|---|
| Subcutaneous injection | Commonly reported at 200-500 mcg per injection, roughly 2x weekly, sometimes framed as once-weekly given the claimed extended half-life. No clinical dosing standard exists; these figures come from self-experimentation reporting, not trials. |
Side effects
- injection site irritation
- theoretical hypoglycemia risk from IGF-1 receptor activation
- unknown long-term effects of chronic PEG accumulation (a general PEGylation concern seen with other pegylated biologics, not established for PEG-MGF specifically)
Safety notes
Community & reddit notes (anecdotal — not clinical evidence)
Discussed in bodybuilding and peptide self-experimentation circles as the 'systemic' counterpart to local MGF injections, used post-training with claims of prolonged muscle-building signaling. Reports are anecdotal; users generally acknowledge there's no controlled human trial behind the protocols being passed around.